SCHEMBL17708146

SCHEMBL17708146

CC1CN(c2ccc(C(C)(C)C)cc2OC(F)F)CC(C)O1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ KMT2A Q03164 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SIGMAR1 Q99720 3/20 0.39
▸ EBP Q15125 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ GAA P10253 2/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ TSHR P16473 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ PDE4D Q08499 4/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ PDE3B Q13370 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17708157 0.84 HCRTR1 (0.33) ALDH1A1HSD17B10KMT2AMEN1SMN1; SMN2
SCHEMBL16437246 0.84 KMT2A (0.47) ALDH1A1HSD17B10KMT2AMEN1NPC1
SCHEMBL17708402 0.83 ALDH1A1 (0.43) ALDH1A1KMT2AMEN1NPC1ALOX12
SCHEMBL17708145 0.79 ALDH1A1 (0.45) ALDH1A1KMT2AMEN1ALOX12KDM4E
SCHEMBL19527768 0.78 ALDH1A1 (0.42) ALDH1A1KMT2AMEN1NPC1ALOX12
SCHEMBL19012390 0.78 KDM4E (0.51) ALDH1A1HSD17B10KMT2AMEN1NPC1
SCHEMBL19012688 0.78 KDM4E (0.51) ALDH1A1HSD17B10KMT2AMEN1NPC1
SCHEMBL19012553 0.78 SIGMAR1 (0.44) ALDH1A1HSD17B10KMT2AMEN1NPC1
SCHEMBL19012691 0.78 SIGMAR1 (0.44) ALDH1A1HSD17B10KMT2AMEN1NPC1
SCHEMBL17708147 0.76 CNR2 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10005777-B2 Protein kinase C inhibitors and uses thereof RIGEL PHARMACEUTICALS, INC. (US) 2018-06-26 — — US disclosed
US-20180030050-A1 Protein Kinase C Inhibitors and Uses Thereof MIDCAP FINANCIAL TRUST 2018-02-01 — — US disclosed
US-9682976-B2 Protein kinase C inhibitors and uses thereof RIGEL PHARMACEUTICALS, INC. (US) 2017-06-20 — — US disclosed
US-9682976-B2 Protein kinase C inhibitors and uses thereof RIGEL PHARMACEUTICALS, INC. (US) 2017-06-20 — — US disclosed
US-20160257681-A1 Protein Kinase C Inhibitors and Uses Thereof MIDCAP FINANCIAL TRUST 2016-09-08 — — US disclosed
US-9321763-B2 Protein kinase C inhibitors and uses thereof RIGEL PHARMACEUTICALS, INC. (US) 2016-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10005777-B2 Protein kinase C inhibitors and uses thereof PRKCH, PRKCA, PRKCB ALDH1A1 4361/4885HSD17B10 2599/4885KMT2A 3505/4885
US-20160257681-A1 Protein Kinase C Inhibitors and Uses Thereof PRKCH, PRKCA, PRKCB ALDH1A1 4361/4885HSD17B10 2599/4885KMT2A 3505/4885
US-20180030050-A1 Protein Kinase C Inhibitors and Uses Thereof PRKCH, PRKCA, PRKCB ALDH1A1 4361/4885HSD17B10 2599/4885KMT2A 3505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback